drugset / Trial / NCT00386503

Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions

NCT00386503

Phase 1 Completed 22 enrolled Sanofi
RandomizedCrossoverOpen-labelTreatment

Summary

* Primary Objective: to evaluate the interaction with food after a single oral dose of a fixed combination of amodiaquine (AQ) and artesunate (AS) (COARSUCAM™) in healthy male subjects * Secondary Objective: to assess the clinical and biological safety and tolerability of Coarsucam™

Timeline

Start
2006-06
Primary completion
2006-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule Oral
Subject amodiaquine Other / unclassified Oral

Indications